Treatment of Liver Fibrosis after Hepatitis B with TCM Combined with NAs Evaluated by Noninvasive Diagnostic Methods: A Retrospective Study

Table 3

Comparison of four items of the liver fiber before treatment [M (P25–P75)].

Years	Groups	HA (ng/ml)	PCIII (ng/ml)	CIV (ng/ml)	LN (ng/ml)
0	TCM users	83.40 (57.40–206.30)	13.90 (6.40–41.75)	62.50 (43.80–69.35)	78.50 (44.55–114.20)
	TCM nonusers	118.70 (64.20–194.95)	9.70 (6.05–23.95)	65.60 (33.20–100.90)	79.10 (46.30–106.90)
	value	0.240	0.612	0.228	0.741
1	TCM users	89.60 (62.05–176.05)	6.70 (5.00–23.65)	58.40 (41.65–70.85)	68.40 (40.72–100.60)
	TCM nonusers	160.90 (89.10–268.35)	8.30 (5.15–55.60)	63.20 (31.40–118.95)	58.80 (38.00–88.25)
	value	0.190	0.172	0.071	0.096
2	TCM users	114.50 (95.70–129.40)	12.30 (5.80–43.85)	48.10 (35.20–69.60)	67.30 (44.70–96.48)
	TCM nonusers	131.20 (116.70–144.00)	7.30 (5.10–18.90)	47.70 (33.70–64.05)	57.90 (35.85–98.1)
	value	0.442	0.154	0.001	0.655
3	TCM users	77.10 (63.15–87.00)	9.00 (5.45–18.20)	35.30 (20.40–35.30)	36.44 (24.15–52.98)
	TCM nonusers	130.10 (119.30–149.25)	6.90 (4.30–13.45)	40.01 (23.40–91.90)	50.50 (22.60–77.79)
	value	0.084	0.131	0.000	0.228
4	TCM users	60.90 (58.45–97.50)	13.90(5.50–18.60)	26.90(16.85–44.45)	23.50 (15.10–57.05)
	TCM nonusers	124.40 (114.45–137.20)	12.30 (5.20–18.30)	36.80 (19.55–92.55)	34.80 (22.55–54.20)
	value	0.020	0.499	0.000	0.208
5	TCM users	67.10 (58.95–96.50)^△	10.10 (5.25-17.20)	24.90 (14.90–35.20)^△	39.50 (22.35–72.90)
	TCM nonusers	106.00 (69.9–170.25)	12.40 (6.45–19.55)	32.80 (19.10–71.45)	39.50 (22.35–72.90)
	value	0.008	0.207	0.001	0.053

Note. Compared with that before treatment (0 year) in this group, ; compared with the TCM nonusers after treatment, ^△.